PTG-100
57613
Phase 1 small_molecule completed
Quick answer
PTG-100 for Celiac Disease is a Phase 1 program (small_molecule) at Protagonist Therapeutics, Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protagonist Therapeutics, Inc
- Indication
- Celiac Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed